BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Microsoft
MSFT
|
+$906M |
| 3 |
Visa
V
|
+$730M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$720M |
| 5 |
Amazon
AMZN
|
+$540M |
Top Sells
| 1 |
Apple
AAPL
|
+$482M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$306M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$214M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$203M |
| 5 |
Bank of America
BAC
|
+$153M |
Sector Composition
| 1 | Technology | 27.67% |
| 2 | Consumer Discretionary | 10.07% |
| 3 | Financials | 9.77% |
| 4 | Healthcare | 9.61% |
| 5 | Communication Services | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNA
2101
Verona Pharma
VRNA
$9.21B
| $315K | ﹤0.01% |
21,777
-1,635
| -7% | -$23.6K |
|
2102
EverQuote
EVER
$896M
| $314K | ﹤0.01% |
15,064
-39,691
| -72% | -$828K |
|
2103
United Natural Foods
UNFI
$1.77B
| $313K | ﹤0.01% |
23,924
-17,906
| -43% | -$235K |
|
2104
Atara Biotherapeutics
ATRA
$85.1M
| $312K | ﹤0.01% |
36,724
+21,401
| +140% | +$182K |
|
2105
CryoPort
CYRX
$433M
| $311K | ﹤0.01% |
45,009
-37,644
| -46% | -$260K |
|
2106
TriMas Corp
TRS
$1.59B
| $310K | ﹤0.01% |
12,133
-8,092
| -40% | -$207K |
|
2107
Virgin Galactic
SPCE
$191M
| $310K | ﹤0.01% |
+36,770
| New | +$310K |
|
2108
The Greenbrier Companies
GBX
$1.42B
| $309K | ﹤0.01% |
6,239
-82,143
| -93% | -$4.07M |
|
2109
FNB Corp
FNB
$5.89B
| $308K | ﹤0.01% |
22,545
-13,964
| -38% | -$191K |
|
2110
Consolidated Water Co
CWCO
$529M
| $308K | ﹤0.01% |
11,617
-1,265
| -10% | -$33.6K |
|
2111
United States Natural Gas Fund
UNG
$580M
| $308K | ﹤0.01% |
17,681
+2,299
| +15% | +$40.1K |
|
2112
Knowles
KN
$1.9B
| $308K | ﹤0.01% |
17,846
-26,515
| -60% | -$458K |
|
2113
EPR Properties
EPR
$4.45B
| $308K | ﹤0.01% |
7,333
-14,883
| -67% | -$625K |
|
2114
BrightView Holdings
BV
$1.32B
| $308K | ﹤0.01% |
23,128
-11,926
| -34% | -$159K |
|
2115
LG Display
LPL
$4.46B
| $308K | ﹤0.01% |
74,646
-4,936
| -6% | -$20.3K |
|
2116
ArriVent BioPharma
AVBP
$800M
| $307K | ﹤0.01% |
16,568
+11,909
| +256% | +$221K |
|
2117
Alector
ALEC
$278M
| $307K | ﹤0.01% |
67,592
+23,666
| +54% | +$107K |
|
2118
Denny's
DENN
$264M
| $306K | ﹤0.01% |
43,142
+549
| +1% | +$3.9K |
|
2119
First Hawaiian
FHB
$3.19B
| $306K | ﹤0.01% |
14,748
-2,020
| -12% | -$41.9K |
|
2120
Hilltop Holdings
HTH
$2.18B
| $306K | ﹤0.01% |
9,782
-13,567
| -58% | -$424K |
|
|
WIRE
2121
DELISTED
Encore Wire Corp
WIRE
| $304K | ﹤0.01% |
1,050
-13,083
| -93% | -$3.79M |
|
2122
8x8 Inc
EGHT
$286M
| $304K | ﹤0.01% |
136,914
-29,705
| -18% | -$65.9K |
|
2123
Mural Oncology
MURA
$36M
| $304K | ﹤0.01% |
96,734
+86,226
| +821% | +$271K |
|
2124
Chemours
CC
$2.51B
| $302K | ﹤0.01% |
13,391
-949
| -7% | -$21.4K |
|
2125
Main Street Capital
MAIN
$5.99B
| $301K | ﹤0.01% |
5,961
+5,445
| +1,055% | +$275K |
|